Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk NVO revealed 10 unusual trades.
Delving into the details, we found 60% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $102,960, and 7 were calls, valued at $574,779.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $115.0 for Novo Nordisk, spanning the last three months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Novo Nordisk options trades today is 971.4 with a total volume of 1,071.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Novo Nordisk's big money trades within a strike price range of $60.0 to $115.0 over the last 30 days.
Novo Nordisk Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| NVO | CALL | SWEEP | BEARISH | 01/16/26 | $115.00 | $363.3K | 107 | 208 |
| NVO | CALL | TRADE | BULLISH | 01/16/26 | $60.00 | $51.8K | 56 | 10 |
| NVO | CALL | SWEEP | BULLISH | 03/15/24 | $100.00 | $41.7K | 1.7K | 57 |
| NVO | CALL | SWEEP | BEARISH | 03/15/24 | $105.00 | $39.6K | 4.7K | 137 |
| NVO | PUT | SWEEP | BULLISH | 01/16/26 | $110.00 | $39.1K | 15 | 32 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Novo Nordisk's Current Market Status
- With a trading volume of 2,900,082, the price of NVO is up by 0.79%, reaching $106.51.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 5 days from now.
What Analysts Are Saying About Novo Nordisk
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $120.0.
- An analyst from Morgan Stanley has revised its rating downward to Overweight, adjusting the price target to $120.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
